Globe Biotech Limited company information, Employees & Contact Information

Kardium grabs FDA approval for Globe pulsed field ablation catheter in afib Fierce Biotech

Kane Biotech Completes Enrollment in U.S. Case Series Studies of its revyve® Antimicrobial Wound Gel and Spray GlobeNewswire

‘I think it is actively happening’: Is Boston’s biotech industry doomed? The Boston Globe

Globe Biotech’s Bangavax receives US patent, a first for Bangladesh’s pharma industry Dhaka Tribune

As US cuts research funding, UK plans to invest billions in new biosecurity center Fierce Biotech

Purple Biotech Expands CAPTN-3 Portfolio with IM1305, a Novel Tri-Specific Antibody Targeting TROP2 GlobeNewswire

Purple Biotech CEO Issues Letter to Shareholders GlobeNewswire

NIH still terminating research grants, defying federal orders: Boston Globe Fierce Biotech

‘Disheartening? Yes. Surprising? No.’ Report on the future of biotech in Mass. gives a grim outlook. The Boston Globe

Purple Biotech Announces New Data Supporting the Unique Design of CAPTN-3 Tri-Specific Antibody IM1240 in Collaboration with the Icahn School of Medicine at Mount Sinai GlobeNewswire

Kardium raises $250M as its pulsed field ablation system undergoes FDA review Fierce Biotech

Kane Biotech Completes U.S. FDA 510(k) Submission for revyve® Antimicrobial Wound Cleanser GlobeNewswire

European countries, universities implement initiatives to attract US researchers amid 'brutal funding cuts' Fierce Biotech

Purple Biotech Announces Initiation of Phase 2 Study of NT219 in Patients with Head and Neck Cancer GlobeNewswire

Catalio's $400M fund takes advantage of 'historic buyer's market in biotech' Fierce Biotech

Kane Biotech to Present revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Fall Conference GlobeNewswire

Apollomics hands Asia rights to its lead c-MET inhibitor to Taiwan’s LaunXP in $60M deal Fierce Biotech

Medtronic to spin out diabetes division as $2.8B independent player Fierce Biotech

Nxera sells APAC license to lupus drug to Viatris for $10M upfront Fierce Biotech

Boston Scientific backs mitral valve developer 4C Medical in $175M round Fierce Biotech

Purple Biotech Announces Pricing of Up To $18 Million Public Offering GlobeNewswire

Amid biotech slump, lab tech jobs are getting harder to come by. Trainees keep trying anyway. The Boston Globe

PDS Biotech Announces Conference Call and Webcast for Second Quarter 2025 Financial Results GlobeNewswire

Unleased lab space. Plunging valuations. Layoffs. In Massachusetts, the biotech slump is taking its toll. Boston.com

China's share of trials jumps, along with enrollment times: IQVIA report Fierce Biotech

Market Insights: What’s Driving the Shift Toward FSP Models in Clinical Development? Fierce Biotech

Moderna co-founder Robert Langer's son launches new VC with $77.5M, backing from dad Fierce Biotech

Novo Nordisk and Variant set out to find new metabolic treatments, pay communities that share genetic data Fierce Biotech

Fortress Biotech and Subsidiary Urica Therapeutics Announce GlobeNewswire

Flagship-backed Sail Biomedicines lays off staff following review of organizational structure Fierce Biotech

Flagship's embattled Laronde sets sail with Senda in merger Fierce Biotech

Purple Biotech Appoints Shai Lankry as Chief Financial Officer GlobeNewswire

Kane Biotech Announces Second Quarter 2025 Financial Results GlobeNewswire

Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101 GlobeNewswire

PCI Biotech half-year interim 2025 report GlobeNewswire

PharmaLegacy acquires BTS Research in hopes of becoming a 'highly competitive global CRO' Fierce Biotech

Veeda expands into international markets with Heads acquisition Fierce Biotech

Kane Biotech Provides Further Corporate Update GlobeNewswire

Purple Biotech Granted New U.S. Patent for NT219 in GlobeNewswire

With MDMA debate spreading beyond biotech, Lykos CEO tries to dispel efficacy, safety concerns Fierce Biotech

Purple Biotech Advances NT219 into Phase 2 Head and Neck Cancer Trial GlobeNewswire

MAIA Biotechnology Announces $736,600 Private Placement GlobeNewswire

Kane Biotech Announces Canadian Distribution Agreement With GlobeNewswire

Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with pioneer as co-founder Fierce Biotech

Evaxion Biotech Secures Equity Financing of up to $40 Million from Lincoln Park Capital GlobeNewswire

Boston biotech backers quit Dana-Farber board after U-turn on investment policy: report Fierce Biotech

Purple Biotech Expands Pipeline of First-in-Class GlobeNewswire

Globe Biotech's Covid vaccine 'Bangavax' secures US patent The Financial Express

Steba Biotech receives FDA Orphan Drug Designation for Padeliporfin ImPACT in Upper Tract Urothelial Cancer GlobeNewswire

Biotech and health care The Boston Globe

Covid-19: Globe Biotech finally gets nod to start human trials of Bangavax Dhaka Tribune

Ipsen moves U.S. headquarters to Kendall Square Fierce Biotech

Evaxion Biotech Appoints Industry Veteran Glenn S. Vraniak GlobeNewswire

Globe Biotech gets permission to manufacture Covid-19 vaccine for trial Dhaka Tribune

Bangladeshi firm Globe Biotech in race to develop Covid-19 vaccine The Financial Express